Cancer Screening in Singapore: What You Should Know (2025)

Cancer Screening in Singapore: What You Need to Know

What Is Cancer Screening?

Cancer screening refers to medical tests that detect cancer at an early stage, often before symptoms appear. These tests look for abnormal cellular changes, such as dysplasia (irregular cell growth), atypical hyperplasia (an unusual increase in cell numbers), or genetic mutations that may increase the risk of cancer. By identifying these initial changes, screening helps detect precancerous conditions or early-stage cancer.

Cancer Rate in Singapore

In Singapore, cancer remains a major health concern, with an average of 46 new diagnoses daily and 16 cancer-related deaths each day between 2017 to 2021.

Among men, the three most common cancers are:

  • Prostate cancer: 6,912 cases (16.8% of all male cancers)
  • Colorectal cancer: 6,697 cases (16.3%)
  • Lung cancer: 5,567 cases (13.5%)
A bar chart showing the top cancers in men in Singapore from 2017 to 2021, highlighting prostate, colorectal, and lung cancers.

Among women, the three most common cancers are:

  • Breast cancer: 12,735 cases (29.7% of all female cancers)
  • Colorectal cancer: 5,542 cases (12.9%)
  • Lung cancer: 3,388 cases (7.9%)
A bar chart showing the top cancers in women in Singapore from 2017 to 2021, highlighting breast, colorectal, and lung cancers.

Why Is Cancer Screening Important?

Screening plays a critical role in improving treatment outcomes by detecting cancer at its most treatable stage. Certain cancers, including breast, cervical, and colorectal cancer, have significantly higher survival rates when diagnosed early. In addition to identifying existing cancer, screening can detect precancerous conditions, allowing for preventive measures that may stop cancer from developing.

What Types of Cancer Screening Are Available?

Cancer screening methods vary based on how they detect abnormal changes in the body. These tests fall into three main categories: laboratory tests, imaging scans, and direct tissue examinations. Each method serves a specific purpose in detecting cancerous or precancerous conditions.

Laboratory and Biomarker Tests

These tests analyse blood, urine, or stool samples to detect cancer-related markers or abnormal cell changes. Some are used for early detection, while others help assess risk or monitor cancer progression. Common examples include:

  • Blood tests for tumour markers
  • HPV testing for cervical cancer
  • Faecal Occult Blood Test (FOBT) for colorectal cancer
  • Liquid biopsy to detect circulating tumour DNA (ctDNA)
Gloved hand holding a blood sample labeled 'HPV Test', with test tubes in the background, depicting HPV testing for cervical cancer.

Imaging-Based Screening Tests

These tests use non-invasive scanning technology to detect tumours or abnormal tissue changes. They are commonly used as first-line screening tools for cancers affecting solid organs and may also guide further diagnostic procedures. Examples include:

  • Mammograms for breast cancer
  • Low-dose CT scans for lung cancer
  • Liver ultrasound for liver cancer

Direct Examination Tests

These tests allow doctors to visually inspect tissues or collect samples for microscopic analysis. They are typically performed when screening tests suggest abnormalities or when a more detailed evaluation is necessary. Unlike screening tests, biopsies provide a definitive diagnosis by confirming whether cancer is present. Examples include:

  • Colonoscopy for colorectal cancer
  • Endoscopy for oesophageal and stomach cancer
  • Biopsy for suspicious tissue growths
A specialist in blue surgical gloves holding an endoscope, a flexible tube with a light and camera used for colonoscopy and endoscopy.

How Often Should You Go for Cancer Screening?

The recommended frequency of cancer screening depends on factors such as age, gender, medical history, and individual risk factors. Below are common cancers screened and their recommended tests:

Screening Test Description Frequency
Cervical Cancer
PAP Smear A small sample of cervical cells is collected using a soft brush and examined under a microscope to detect precancerous or abnormal cell changes in the cervix. Females aged 25 to 29: Every 3 years
HPV Test A cervical cell sample is tested for high-risk human papillomavirus (HPV) strains, which may cause cervical cancer. This test can be performed using the same sample as a PAP smear. Females aged 30 and above: Every 5 years
Breast Cancer
Mammogram A low-dose X-ray scan compresses the breast tissue to capture detailed images, detecting lumps or abnormal growths. Females aged 40 and above: Every year
Prostate Cancer
Prostate-Specific Antigen (PSA) Test A blood test measures PSA levels, which may be elevated in prostate cancer or other prostate conditions. High-risk males aged 50 and above
Colorectal Cancer
Stool Occult Blood Test (Faecal Immunochemical Test) A stool sample is tested for microscopic traces of blood, which requires further evaluation to test for polyps, inflammation, gastrointestinal conditions or colorectal cancer. All individuals aged 50 and above: Every year
Colonoscopy A flexible tube with a camera is inserted into the colon to check for polyps or abnormal growths. It can also be used to remove polyps or precancerous lesions. All individuals aged 50 and above: Every 10 years (or earlier if at high risk)
Lung Cancer
Low-dose CT scan A non-invasive imaging test that uses low-dose radiation to scan the lungs for tumours or abnormalities. High-risk individuals aged 55 and above: Every year
Liver Cancer
Liver Function Tests A blood test that measures liver enzyme levels, which can indicate liver disease or dysfunction. Individuals at risk
Ultrasound A non-invasive scan using sound waves to detect liver tumours or abnormalities. Individuals at risk

Screening for breast, cervical, and colorectal cancer is recommended under the Health Promotion Board (HPB) Screen for Life programme. For other cancers, screening recommendations depend on individual risk factors, so it is best to consult a doctor to determine the most appropriate screening schedule for you.

How Much Does Cancer Screening Cost in Singapore?

At ATA Medical, we offer a range of cancer screening tests with the following price list:

Screening Test Price*
Consultation From $38.15
Cervical Cancer
PAP Smear From $0
HPV Test From $0
Breast Cancer
Mammogram $201.65
Ultrasound Breast + Mammogram $305.20
Prostate Cancer
Prostate-Specific Antigen (PSA) Test $38.15
Colorectal Cancer
Stool Occult Blood Test (Faecal Immunochemical Test) $27.25
Colonoscopy From $2398
Lung Cancer
Low-dose CT Scan $403.30
Liver Cancer
Liver Function Tests From $30.52
Ultrasound Liver $150.42
Other Tests
Liquid Biopsy From $1098
*Prices are NETT and inclusive of GST.

We also offer additional diagnostic tests such as X-rays, MRI, and CT scans for further evaluation if needed.

Subsidies and MediSave Claims

As a CHAS-accredited clinic, we offer subsidies for eligible cancer screenings under Screen for Life (SFL). Selected procedures may also be claimable via MediSave, subject to eligibility criteria. Please contact us for more details on financing options and eligibility.

Comprehensive Health Screening Packages

For a more in-depth health assessment, consider our comprehensive health screening packages, which can include multiple tests to screen for various cancers and other medical conditions.

Why Choose ATA Medical?

ATA Medical - One Stop Health Screening Clinic with X Ray, CT Scan, Mammogram and Ultrasound scans.
ATA Medical - One Stop Health Screening Clinic with X Ray, CT Scan, Mammogram and Ultrasound scans.
ATA Medical Orchard Clinic with Health Screening Nurses and Staff
Orchard Clinic
ATA Medical Tanjong Pagar Clinic with Health Screening Nurses and Staff
Tanjong Pagar Clinic
Patient having a health screening review with Dr Jana Lim of ATA Medical
Health Screening Review with Dr Jana Lim
Female patient undergoing ultrasound scan procedure at ATA Medical Clinic.
Mammograms & Ultrasound Scans with Female Staff
Female patient getting ready to undergo X-Ray procedure with a male staff assisting with the preparations.
One-Stop Clinic with X-Ray Facilities
Dr Leonard Leng of ATA Medical having a consultation session with a male patient.
Consultation About Men or Female Health With a Doctor of Your Choice

Making a Difference Together

At ATA Medical, we strive to make a meaningful impact on every patient's health. With over 120,000 patients served, we are dedicated to fostering trust and enhancing well-being across our community.

+

Patients

+

Health Screening Tests

+

Corporate Screenings

Our Esteemed Clientele Include

Esteemed clientele of ATA Medical include: Google, Smart Nation Singapore, SkillsFuture Singapore, J.P. Morgan, Samsung Electronics, and NTUC Income.

What to Expect

FAST RESULTS

We strive to deliver your results within 7 working days.

MINIMUM WAITING TIME

Our patient-oriented processes ensure your waiting time is kept to a minimum.

Friendly Service

Service is a top priority for us at ATA Medical.

Want to do health screening in the comforts of your home with your family or partner? Try our home-based health screening.

Email Us at camden@atamed.sg for More Information.

Book Your Health Screening With Us at 88838892.

Frequently Asked Questions (FAQs)

Cervical cancer screening costs vary depending on the test and eligibility for subsidies. At ATA Medical, a PAP smear and HPV test start from $0 under the Screen for Life (SFL) programme, subject to eligibility. Contact us to check your eligibility and learn more about financing options.
The recommended frequency for cervical cancer screening depends on age and risk factors. Women aged 25 to 29 should undergo a Pap smear every 3 years, while those 30 and above should have an HPV test every 5 years. The HPV test can be performed on the same sample as a PAP smear, reducing the need for multiple procedures. More frequent testing may be required for individuals with abnormal results or higher risk factors. Consulting a doctor can help determine the most suitable screening schedule for you.
At ATA Medical, blood tests for tumour markers, such as the Prostate-Specific Antigen (PSA) test, start from $38.15, while more advanced screenings, including liquid biopsies, start from $1,098. We also offer comprehensive health screening packages that include selected cancer marker tests along with other cancer screening tests, providing a more holistic assessment of your health.
Blood tests can detect tumour markers or biological changes that may indicate cancer, but they do not confirm it on their own. Some cancers release specific proteins, such as Prostate-Specific Antigen (PSA) for prostate cancer or Alpha-Fetoprotein (AFP) for liver cancer, which may suggest cancer or other conditions. Liquid biopsy can also detect circulating tumour DNA (ctDNA) to identify genetic mutations linked to certain cancers. However, these tests are not definitive, and abnormal results require further imaging or biopsy tests for confirmation.
Liver cancer screening typically involves a blood test for Alpha-Fetoprotein (AFP) and an ultrasound scan to detect abnormal growths in the liver. Individuals with risk factors such as hepatitis B, cirrhosis, or a family history of liver cancer may require more frequent screening. If abnormalities are detected, additional imaging tests such as CT or MRI scans may be recommended for further evaluation. Consulting a doctor can help determine the most appropriate screening frequency based on your individual risk factors.
Cervical cancer screening is done through a PAP smear or HPV test. A Pap smear examines cervical cells under a microscope for precancerous changes, while an HPV test detects high-risk HPV strains that may cause cervical cancer. Women aged 25 to 29 are advised to have a Pap smear every 3 years, while those 30 and above should undergo an HPV test every 5 years. Both tests can be performed on the same sample, reducing the need for multiple procedures.
At ATA Medical, we offer cancer screening tests for various cancers, including a Faecal Immunochemical Test ($27.25) for colorectal cancer, Prostate-Specific Antigen (PSA) test ($38.15) for prostate cancer, and mammogram ($201.65) for breast cancer. Subsidised rates may be available under the Screen for Life (SFL) programme for eligible individuals. We also provide comprehensive health screening packages that include a combination of blood tests, imaging scans, and cancer marker tests to assess various cancers and other health conditions. Contact us for more information on available screenings and pricing.
Cancer screening in Singapore includes blood tests, imaging scans, and direct examination procedures. Common screenings include Pap smears and HPV tests for cervical cancer, mammograms for breast cancer, FIT stool tests and colonoscopy for colorectal cancer, and PSA tests for prostate cancer. Imaging tests such as low-dose CT scans for lung cancer and ultrasounds for liver cancer are also available. Screening recommendations depend on age, risk factors, and medical history, so consult a doctor to determine the most appropriate screenings for you.
There is no single "full body cancer screening" test, but a comprehensive cancer or health screening package can include multiple tests based on your risk factors. These may include tumour marker blood tests, imaging scans (e.g., CT, MRI, ultrasound), and direct examination procedures like endoscopy or colonoscopy. Consulting a doctor can help determine the most appropriate screening plan based on your medical history and risk factors.
Yes, polyclinics in Singapore provide basic cancer screening services, including PAP smears for cervical cancer, FIT stool tests for colorectal cancer, and referrals for mammograms. These screenings are available under the Screen for Life (SFL) programme, with subsidies for eligible individuals. At ATA Medical, we offer a range of individual cancer screenings and comprehensive health screening packages, which include blood tests and imaging scans for a more thorough health assessment. Contact us for more information on availability and pricing.
Cancer screening is important because early detection improves treatment outcomes and survival rates. Screening can identify precancerous changes or early-stage cancer, allowing for prompt intervention before symptoms develop. However, not all screenings are necessary for everyone, as overtesting may lead to unnecessary procedures or false positives. Consulting a doctor can help determine which screenings are appropriate based on age, medical history, and individual risk factors.
The recommended age for cancer screening depends on the type of cancer and individual risk factors. In Singapore, cervical cancer screening is recommended to start from age 25, colorectal and breast cancer screenings from age 50. Those with a family history of cancer or other risk factors may need earlier or more frequent screenings. Consulting a doctor can help determine the most suitable screening schedule for you.
The most common cancer in Singapore differs between men and women. Among men, prostate cancer is the most common, followed by colorectal and lung cancer. Among women, breast cancer is the leading cancer, followed by colorectal and lung cancer. These cancers account for a significant proportion of cancer cases and deaths, highlighting the importance of regular screening and early detection.
Cancer screening recommendations depend on age, gender, medical history, and individual risk factors. In Singapore, the Screen for Life (SFL) programme offers subsidised screenings for breast, cervical, and colorectal cancer to Singaporean citizens and PRs who meet certain criteria. Individuals with a family history of cancer, chronic conditions, or lifestyle risks may also be advised to undergo screening. Consulting a doctor can help determine the most appropriate screenings based on your health profile.
Cancer symptoms vary by type and stage, but common warning signs include unexplained weight loss, persistent fatigue, bowel changes, difficulty swallowing, chronic cough, unexplained bleeding, and abnormal lumps. Other possible symptoms include chronic pain, skin changes, non-healing sores, or persistent bloating. While these symptoms do not always indicate cancer, regular screenings based on medical guidelines and individual risk factors can support early detection and improved treatment outcomes. It is best to consult a doctor to determine the most appropriate screening schedule for your health needs.
Some cancers are difficult to detect early due to their lack of symptoms in the initial stages. Pancreatic, ovarian, lung, and liver cancers are among the most challenging to detect early, as symptoms often appear only in later stages. Additionally, aggressive cancers like glioblastoma (brain cancer) and some forms of leukaemia can progress rapidly before diagnosis. Regular screenings and monitoring of risk factors can help detect certain cancers earlier when treatment is more effective.
Yes, a general practitioner (GP) can assess your cancer risk and recommend appropriate screening tests. At ATA Medical, we provide screenings for breast, cervical, colorectal, lung, liver, and other cancers. Screen for Life (SFL) subsidies are available for certain screenings. For a more comprehensive health assessment, we also offer health screening packages that include multiple tests for cancer detection and other medical conditions. Contact us for more information on screenings and pricing.